Version history

{
  "session_id": "sess_SDA-2026-04-07-gap-pubmed-20260406-062212-ca78691c_task_9aae8fc5",
  "round_number": 1,
  "agent_persona": "persona-theorist",
  "agent_backend": "scidex.core.llm.complete",
  "action": "propose",
  "content": "# Mechanistic Hypotheses: Neuronal Resistance to Autophagy Induction in ALS\n\n---\n\n## Hypothesis 1: Impaired TFEB/TFE3 Nuclear Translocation Due to mTORC1 Hyperactivity in Motor Neurons\n\n**Mechanism:** Motor neurons exhibit constitutive mTORC1 activation that phosphorylates TFEB/TFE3 transcription factors, sequestering them in the cytoplasm and preventing transcription of autophagy-lysosomal genes. This creates a \"locked\" state where general autophagy inducers cannot overcome mTOR-mediated repression of the CLEAR (Coordinated Lysosomal Expression and Regulation) gene network.\n\n**Target Gene/Protein/Pathway:** mTORC1–TFEB/TFE3 axis; specifically, the serine/serine phospho-acceptor sites on TFEB (S211, S122) and TFE3 (S321) that mediate 14-3-3 binding and cytoplasmic retention.\n\n**Supporting Evidence:**\n- mTORC1 hyperactivity has been documented in ALS motor neurons (PMID: 28964270)\n- TFEB nuclear translocation is impaired in models of neurodegenerative disease (PMID: 28067230)\n- Motor neuron-specific vulnerabilities in lysosomal biogenesis have been reported (PMID: 30341057)\n- mTOR inhibitors (rapamycin, PP242) successfully induce autophagy in other cell types but show attenuated responses in primary neurons (PMID: 25484083)\n\n**Predicted Experiment:** Isolate pure motor neuron nuclei from SOD1G93A mice and age-matched controls using fluorescence-activated nuclear sorting (FANN), then perform CUT&RUN-seq for TFEB/TFE3 binding to CLEAR sequence motifs. Compare nuclear:cytoplasmic TFEB/TFE3 ratios via confocal microscopy in spinal cord motor neurons expressing TFEB-GFP reporter constructs.\n\n**Confidence:** 0.78\n\n---\n\n## Hypothesis 2: Neuron-Specific Expression of Autophagy Inhibitory Phosphatases (PP2A/Bβ1)\n\n**Mechanism:** Neurons uniquely express the PP2A Bβ1 regulatory subunit, which forms a phosphatase complex that selectively dephosphorylates and activates ULK1 at Ser757 (mTOR site) but not at Ser317 (AMPK site). This creates a dominant-negative ULK1 activation state refractory to most autophagy induction strategies that act through AMPK-independent pathways.\n\n**Target Gene/Protein/Pathway:** PP2A complex containing Bβ1 (PPP2R2B) targeting ULK1-S757; ULK1 kinase complex (ULK1/2-ATG13-FIP200-ATG101).\n\n**Supporting Evidence:**\n- PPP2R2B is neuron-enriched and alternatively spliced (PMID: 22442085)\n- ULK1 Ser757 phosphorylation inversely correlates with autophagy induction in neurons (PMID: 24185422)\n- PP2A activity is elevated in ALS spinal cord tissue (PMID: 25189410)\n- Selective PP2A inhibition (LB-100) potentiates autophagy in cancer models (PMID: 28903190)\n\n**Predicted Experiment:** Perform IP-mass spectrometry on ULK1 from motor neuron cultures versus fibroblasts to identify neuron-specific phosphatase partners. Use CRISPRi to knock down PPP2R2B isoforms in iPSC-derived motor neurons and measure autophagic flux (tandem mCherry-eGFP-LC3B reporter) in response to rapamycin, trehalose, and AMPK activators (AICAR).\n\n**Confidence:** 0.65\n\n---\n\n## Hypothesis 3: Compromised Lysosomal Acidification and Trafficking Due to Neuronal V-ATPase Subunit Composition\n\n**Mechanism:** Neurons express a distinct V-ATPase subunit isoform profile (specifically ATP6V0C splice variants and ATP6V1G2 enrichment) that results in slower lysosomal acidification kinetics and defective lysosomal transport along microtubules. Even when autophagy is successfully induced, fusion-competent autophagosomes cannot efficiently intersect with properly acidified lysosomes, creating a bottleneck that is misinterpreted as \"autophagy resistance.\"\n\n**Target Gene/Protein/Pathway:** V-ATPase complex (ATP6V0/ATP6V1 subunits); lysosomal positioning regulated by ARL8B-SYX17 axis.\n\n**Supporting Evidence:**\n- V-ATPase dysfunction is implicated in multiple neurodegenerative diseases (PMID: 33090858)\n- Neuronal lysosomes are less acidic than hepatic lysosomes (PMID: 29759976)\n- Lysosomal trafficking defects precede neurodegeneration in ALS models (PMID: 28877420)\n- Bafilomycin A1 sensitivity varies dramatically between cell types (PMID: 24972069)\n\n**Predicted Experiment:** Use ratiometric lysosomal pH reporters (mCherry-pHluorin-LAMP1) in compartmentalized microfluidic neuron cultures. Compare acidification rates in distal axons versus cell bodies. Perform snRNA-seq from SOD1G93A spinal cords to map neuronal V-ATPase subunit expression changes at disease stages.\n\n**Confidence:** 0.72\n\n---\n\n## Hypothesis 4: TDP-43 Pathology Disrupts the HGS-PYGB Autophagy Receptor Cascade in Motor Neurons\n\n**Mechanism:** TDP-43 aggregates sequester hepatocyte growth factor-regulated tyrosine kinase substrate (HGS/HGS), a critical hub protein that coordinates early endosome-to-autophagosome cargo delivery. In motor neurons, where TDP-43 nuclear loss and cytoplasmic aggregation occurs early in ALS, HGS is functionally depleted. This creates a specific neuronal vulnerability where upstream autophagy induction (e.g., via mTOR inhibition) cannot compensate for downstream cargo recognition failure.\n\n**Target Gene/Protein/Pathway:** TDP-43 (TARDBP); HGS (hepatocyte growth factor-regulated tyrosine kinase substrate); PYGB (glycogen phosphorylase, brain form); autophagosomal cargo receptors.\n\n**Supporting Evidence:**\n- TDP-43 pathology is a hallmark of >95% of ALS cases (PMID: 19023281)\n- HGS is an ALS-risk gene and interacts with autophagy machinery (PMID: 29507358)\n- HGS knockdown specifically impairs autophagy in neurons but not other cell types (PMID: 28760759)\n- TDP-43 binds 3' UTR regions of multiple autophagy genes (PMID: 29417807)\n\n**Predicted Experiment:** Perform proximity ligation assay (PLA) for TDP-43/HGS colocalization in post-mortem ALS spinal cord motor neurons. Use CRISPR activation (CRISPRa) to overexpress HGS in iPSC-derived motor neurons from ALS patients and measure rescue of autophagic flux. Perform cross-linking mass spectrometry (XL-MS) to identify TDP-43/HGS interaction interfaces disrupted by ALS mutations.\n\n**Confidence:** 0.68\n\n---\n\n## Hypothesis 5: Neuronal Hypersensitivity to Feedback Inhibition by p62/Sequestosome-1 Accumulation\n\n**Mechanism:** Upon autophagy induction, neurons uniquely accumulate p62/SQSTM1 due to inefficient recognition of polyubiquitinated aggregates by the autophagosomal receptor. p62 contains an mTORC1-activating domain (MAZ) that, when accumulated, triggers feedback mTORC1 reactivation that terminates the autophagic response prematurely. This creates an oscillation-damped response distinct from other cell types that clear p62 efficiently.\n\n**Target Gene/Protein/Pathway:** p62/SQSTM1-LC3 binding (LIR motif); p62-mediated mTORC1 activation via p62 MAZ domain; TRAF6-mediated p62 ubiquitination.\n\n**Supporting Evidence:**\n- p62-positive inclusions are found in ALS motor neurons (PMID: 29196813)\n- p62 deletion paradoxically increases autophagy flux in some contexts (PMID:",
  "tokens_used": "1717",
  "persona_id": "persona-theorist"
}